CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...